AMANDA OSBORNE: Open Payments
NPI 1346548096 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 29 payments from 14 companies in 2025. Trend: 2023 $988 · 2024 $1,456 · 2025 $656
Food & beverage: $654Education: $2
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 5 | $93 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| NxStage Medical, Inc. | 1 | $66 |
| Fresenius USA Marketing, Inc. | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| Vifor Pharma, Inc. | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $53 |
| Novo Nordisk Inc | 2 | $52 |
| Amgen Inc. | 2 | $40 |
| ANI Pharmaceuticals, Inc. | 1 | $27 |
Products named: FARXIGA, NXSTAGE SYSTEM ONE, VELPHORO, Veltassa, JYNARQUE, Ozempic, TERLIVAZ, ACTHAR.
Industry payments across MS — which companies pay providers there.
